“…All of them are important hypotheses from basic and applied research viewpoints. In this line we set together molecular motifs which resulted important for biological studies and close to our research lines: (i) Schiff bases and their tin and organotin derivatives [38][39][40][41][42][43] have been tested in vitro in antitumor assays showing moderate-good activity; (ii) di-n-butyl-tin IV compounds with ortho-aminophenols presented better antitumor activities and less damage in normal cells when compared against cis-platin [44]; (iii) the statements that di-phenyl-tin IV derivatives could result pretty less toxic than other di-organo-tin IV derivatives due to their interaction towards the cell membrane [10][11][12]37]; (iv) the advantage that in our group there have been prepared three different series of monomeric di-phenyl-tin IV derivatives [34,45,46] with Schiff bases (instead of mono-, di-or polymeric forms when di-n-butyl-tin IV fragments are employed) [34,46,47]; (v) it has been reported one di-phenyl-tin IV compound possessing this set of molecular variables [48], 3 X-ray structures were found in the CCDC, two were reported by our work group [49], and none of them has been biologically tested. Therefore, it merits studying a family of compounds based in this lead di-phenyl-tin IV derivative with single chemical modifications now with the premise of evaluating not one but two biological activities to determine specificity.…”